Model diagnostics for multi-state models

Titman, Andrew C.; Sharples, Linda D.
December 2010
Statistical Methods in Medical Research;Dec2010, Vol. 19 Issue 6, p621
Academic Journal
Multi-state models are a popular method of describing medical processes that can be represented as discrete states or stages. They have particular use when the data are panel-observed, meaning they consist of discrete snapshots of disease status at irregular time points which may be unique to each patient. However, due to the difficulty of inference in more complicated cases, strong assumptions such as the Markov property, patient homogeneity and time homogeneity are applied. It is important that the validity of these assumptions is tested. A review of methods for diagnosing model fit for panel-observed continuous-time Markov and misclassification-type hidden Markov models is given, with illustrative application to a dataset on cardiac allograft vasculopathy progression in post-heart transplant patients.


Related Articles

  • The Role of HLA-Directed Antibodies in Cardiac Transplant Immunology. Tambur, Anat R. // Current Cardiology Reviews;2007, Vol. 3 Issue 3, p207 

    Over the last few years heart transplant physicians have encounted more allograft rejection episodes that are not responsive to conventional treatment. The role of B cells and alloantibodies in organ transplant outcome becomes more apparent. More centers recognize the role of humoral rejection...

  • Cardiac Allograft Vasculopathy. Segura, Ana Maria; Buja, L. Maximilian // Texas Heart Institute Journal;2013, Vol. 40 Issue 4, p400 

    The author discusses cardiac allograft vasculopathy (CAV). CAV is a main sequela that limits the long-term success of cardiac transplantation. A diagnosis of CAV significantly lessens survival time. CAV is one of the main causes of death at three years or longer after transplantation. A basic...

  • Vascular Tissue Plasminogen Activator and the Development of Coronary Artery Disease in Heart-Transplant Recipients. Labarrere, Carlos A.; Pitts, Douglas; Nelson, David R.; Faulk, W. Page // New England Journal of Medicine;10/26/95, Vol. 333 Issue 17, p1111 

    Background: An aggressive and potentially fatal form of coronary artery disease may develop after cardiac transplantation. We studied the role of vascular tissue plasminogen activator (t-PA), the primary mediator of fibrinolysis, in the development of this problem. Methods: We studied 78...

  • Endothelial cell antibody-mediated rejection and successful retransplantation in a heart transplanted patient. Sigurdardottir, Vilborg; Kolsrud, Oscar; Hernandez, Nidia; Dellgren, Göran // European Journal of Cardio-Thoracic Surgery;Dec2012, Vol. 42 Issue 6, p1044 

    Antibody-mediated rejection (AMR) plays a significant role in cardiac allograft dysfunction, and recently a consensus regarding the diagnosis of AMR has been published. To our knowledge, it has not previously been reported that acute graft failure related to AMR, and antiendothelial cell...

  • Global radial strain is reduced in healthy heart transplant patients. Baričević, Željko; Lovrić, Daniel; Čikeš, Maja; Maček, Jana Ljubas; Lukšić, Vlatka Rešković; Vranešić, Irena Ivanac; Hanževački, Jadranka Šeparović; Miličić, Davor // Cardiologia Croatica;May/Jun2013, Vol. 8 Issue 5/6, p153 

    Background: Allograft rejection and vasculopathy in heart transplant (HTx) patients require timely recognition, with coronary angiography and endomyocardial biopsy being the diagnostic gold standards. Finding a non-invasive alternative remains the major objective. Speckle tracking...

  • Tissue Doppler derived strain rather than wall velocities detect microvascular disease in paediatric heart transplant recipients.  // Cardiology in the Young;May2005 Supplement 2, Vol. 15 Issue S2, p25 

    This article cites a study, which attempted to determine whether the tissue derived parameters can detect coronary allograft vasculopathy (CAV) after heart transplantation in children. CAV remains the main cause of graft failure and limiting long term survival after heart transplantation. The...

  • Heart allograft transplanted twice Simsir, Sinan A.; Fontana, Gregory P.; Czer, Lawrence S.; Schwarz, Ernst R. // European Journal of Cardio-Thoracic Surgery;Oct2008, Vol. 34 Issue 4, p918 

    Abstract: We present the case of a man who underwent successful heart transplantation with an allograft that was obtained from a donor who had already received heart transplantation.

  • Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival. Fleury, S.; Li, J.; Simeoni, E.; Fiorini, E.; von Segesser, L. K.; Kappenberger, L.; Vassalli, G. // Gene Therapy;Jul2006, Vol. 13 Issue 14, p1104 

    Vascularized organ allografts are rapidly destroyed by host immune cells that are recruited along chemokine gradients. Among chemokines, Regulated on Activation, Normal T-cell Expressed and Secreted (RANTES) CC chemokine ligand (CCL5) and monocyte chemoattractant protein (MCP)-1 (CCL2) are...

  • CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-, and indoleamine 2,3-dioxygenase. Guillonneau, Carole; Hill, Marcelo; Hubert, François-Xavier; Chiffoleau, Elise; Hervé, Caroline; Xian-Liang Li; Heslan, Michèle; Usal, Claire; Tesson, Laurent; Ménoret, Séverine; Saoudi, Abdelhadi; Le Mauff, Brigitte; Josien, Régis; Cuturi, Maria Cristina; Anegon, Ignacio // Journal of Clinical Investigation;Apr2007, Vol. 117 Issue 4, p1096 

    Treatment with CD40Ig results in indefinite allograft survival in a complete MHC-mismatched heart allograft model in the rat. Here we show that serial second, third, and fourth adoptive transfers of total splenocytes from CD40Ig-treated recipients into secondary recipients led to indefinite...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics